Adjuvant Vitamin C in critically ill patients undergoing renal replacement therapy: What’s the right dose?
Main Authors: | Paul E Marik, Michael H Hooper |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13054-018-2190-y |
Similar Items
-
Response to “Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose”
by: Angelique M. E. Spoelstra – de Man, et al.
Published: (2018-12-01) -
Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review
by: Patrick M. Honore, et al.
Published: (2020-02-01) -
Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
by: Soo Min Jang, et al.
Published: (2020-02-01) -
Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
by: Lu Li, et al.
Published: (2020-05-01) -
Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
by: Weerachai Chaijamorn, et al.
Published: (2018-09-01)